Related references
Note: Only part of the references are listed.Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulin
K. Rave et al.
DIABETES OBESITY & METABOLISM (2009)
Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
Julio Rosenstock et al.
DIABETES CARE (2008)
Inhaled insulin's last gasp?
Jim Kling
NATURE BIOTECHNOLOGY (2008)
Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes
Klaus Rave et al.
DIABETES CARE (2007)
Inhaled dry powder insulin for the treatment of diabetes mellitus
Stephen M. Setter et al.
CLINICAL THERAPEUTICS (2007)
The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin
RHA Becker et al.
DIABETES CARE (2006)
Concept, strategies, and feasibility of noninvasive insulin delivery
WT Cefalu
DIABETES CARE (2004)
When oral agents fail: practical barriers to starting insulin
M Korytkowski
INTERNATIONAL JOURNAL OF OBESITY (2002)
Technosphere (TM)/Insulin - proof of concept study with a new insulin formulation for pulmonary delivery
S Steiner et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2002)
Alternative routes of administration as an approach to improve insulin therapy:: Update on dermal, oral, nasal and pulmonary insulin delivery
L Heinemann et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Share Paper
